1st Quarter - Report

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

Firm
Client
Income
—
Expenses
$125,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Torts TOR

Medical Liability Reform

LobbyistCovered position, as disclosed
CATE BLANKENBURG —
LEANN FOX New —
SHAWN MARTIN —
RAY QUINTERO —

Contacted: Education, Dept of; White House Office; Health Resources & Services Administration (HRSA); Indian Health Service; Substance Abuse & Mental Health Services Administration (SAMHSA); SENATE; Small Business Administration (SBA); Office of Natl Drug Control Policy (NDCP); Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); President of the U.S.; Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC)

Health Issues HCR

Physician Issues, Health Information Technology, Electronic Prescribing, Health System Reform Access and Affordability of Health Care, Public Health

LobbyistCovered position, as disclosed
CATE BLANKENBURG —
LEANN FOX New —
SUSAN FRIEDMAN New —
ANGELA JEANSONNE New —
SHAWN MARTIN —
CAROL MONACO New —
RAY QUINTERO —

Contacted: Office of Natl Drug Control Policy (NDCP); Small Business Administration (SBA); Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Education, Dept of; Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Indian Health Service; Centers For Disease Control & Prevention (CDC); President of the U.S.; Substance Abuse & Mental Health Services Administration (SAMHSA); White House Office; Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

Physician Payment, SCHIP Reauthorization, Graduate Medical Education, Quality and Patient Safety

LobbyistCovered position, as disclosed
CATE BLANKENBURG —
LEANN FOX New —
SUSAN FRIEDMAN New —
ANGELA JEANSONNE New —
SHAWN MARTIN —
CAROL MONACO New —
RAY QUINTERO —

Contacted: Small Business Administration (SBA); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Indian Health Service; HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); President of the U.S.; Office of Natl Drug Control Policy (NDCP); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); White House Office; Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Education, Dept of; Centers For Disease Control & Prevention (CDC)

Budget/Appropriations BUD

Labor, Health, and Human Serivces, and Education

LobbyistCovered position, as disclosed
CATE BLANKENBURG —
SUSAN FRIEDMAN New —
ANGELA JEANSONNE New —
SHAWN MARTIN —
CAROL MONACO New —
RAY QUINTERO —

Contacted: Small Business Administration (SBA); White House Office; Indian Health Service; Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Office of Natl Drug Control Policy (NDCP); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; President of the U.S.; Food & Drug Administration (FDA); Education, Dept of; Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA)

Tobacco TOB

FDA Oversight of Tobacco

LobbyistCovered position, as disclosed
CATE BLANKENBURG —
ANGELA JEANSONNE New —
SHAWN MARTIN —
RAY QUINTERO —

Contacted: Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ); SENATE; Medicare Payment Advisory Commission (MedPAC); White House Office; Substance Abuse & Mental Health Services Administration (SAMHSA); Indian Health Service; President of the U.S.; Centers For Disease Control & Prevention (CDC); Office of Natl Drug Control Policy (NDCP); Centers For Medicare and Medicaid Services (CMS); Education, Dept of; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Small Business Administration (SBA)

Education EDU

Student Loan Issues Education Financing and Repayment

LobbyistCovered position, as disclosed
CATE BLANKENBURG —
LEANN FOX New —
ANGELA JEANSONNE New —
SHAWN MARTIN —
CAROL MONACO New —
RAY QUINTERO —

Contacted: Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); White House Office; Indian Health Service; Substance Abuse & Mental Health Services Administration (SAMHSA); SENATE; Health Resources & Services Administration (HRSA); Small Business Administration (SBA); Office of Natl Drug Control Policy (NDCP); Education, Dept of; Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); President of the U.S.

Medical/Disease Research/Clinical Labs MED

NIH Funding Agency for Health Qualtiy and Research Funding

LobbyistCovered position, as disclosed
CATE BLANKENBURG —
LEANN FOX New —
SUSAN FRIEDMAN New —
ANGELA JEANSONNE New —
SHAWN MARTIN —
CAROL MONACO New —
RAY QUINTERO —

Contacted: Small Business Administration (SBA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Indian Health Service; Office of Natl Drug Control Policy (NDCP); President of the U.S.; Medicare Payment Advisory Commission (MedPAC); SENATE; Education, Dept of; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); White House Office; Substance Abuse & Mental Health Services Administration (SAMHSA); Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ); Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.